Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Titball

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
Clinical Therapeutics|August 24, 2010
Progress toward development of vaccines against melioidosis: A reviewMitali Sarkar-Tyson, Richard W Titball
Annals of the New York Academy of Sciences|April 17, 2007
Francisella tularensis genomics and proteomicsRichard W Titball, Joseph F Petrosino
Nature Medicine|March 8, 2007
A plague upon fibrinRichard W Titball, Petra C F Oyston
Trends in Microbiology|March 22, 2003
Will the enigma of Francisella tularensis virulence soon be solved?Richard W Titball, Anders Johansson, Mats Forsman
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 22, 2023
Is <i>Clostridium perfringens</i> epsilon toxin associated with multiple sclerosis?Richard W Titball, Nicholas Lewis, Richard Nicholas
NPJ Vaccines|April 19, 2024
Strep A: challenges, opportunities, vaccine-based solutions and economicsDavid E Bloom, Richard W Titball, Jonathan Carapetis
Journal of Fungi (Basel, Switzerland)|September 12, 2018
Standardization of Olivia L Champion, Richard W Titball, Steven Bates
Virulence|July 1, 2016
Galleria mellonella as a model host for microbiological and toxin researchOlivia L Champion, Sariqa Wagley, Richard W Titball
FEMS Microbiology Reviews|November 5, 2002
Salmonella vaccines for use in humans: present and future perspectivesHelen S Garmory, Katherine A Brown, Richard W Titball
FEMS Microbiology Letters|October 23, 2012
Identification of type II toxin-antitoxin modules in Burkholderia pseudomalleiAaron Butt, Claudia Müller, Nicholas Harmer, et al.
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Clinical Therapeutics|August 24, 2010
Progress toward development of vaccines against melioidosis: A reviewMitali Sarkar-Tyson, Richard W Titball
Annals of the New York Academy of Sciences|April 17, 2007
Francisella tularensis genomics and proteomicsRichard W Titball, Joseph F Petrosino
Nature Medicine|March 8, 2007
A plague upon fibrinRichard W Titball, Petra C F Oyston
Trends in Microbiology|March 22, 2003
Will the enigma of Francisella tularensis virulence soon be solved?Richard W Titball, Anders Johansson, Mats Forsman
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 22, 2023
Is <i>Clostridium perfringens</i> epsilon toxin associated with multiple sclerosis?Richard W Titball, Nicholas Lewis, Richard Nicholas
NPJ Vaccines|April 19, 2024
Strep A: challenges, opportunities, vaccine-based solutions and economicsDavid E Bloom, Richard W Titball, Jonathan Carapetis
Journal of Fungi (Basel, Switzerland)|September 12, 2018
Standardization of Olivia L Champion, Richard W Titball, Steven Bates
Virulence|July 1, 2016
Galleria mellonella as a model host for microbiological and toxin researchOlivia L Champion, Sariqa Wagley, Richard W Titball
FEMS Microbiology Reviews|November 5, 2002
Salmonella vaccines for use in humans: present and future perspectivesHelen S Garmory, Katherine A Brown, Richard W Titball
FEMS Microbiology Letters|October 23, 2012
Identification of type II toxin-antitoxin modules in Burkholderia pseudomalleiAaron Butt, Claudia Müller, Nicholas Harmer, et al.
Pageof 23